Prieto-Alhambra, D.
Moral-Cuesta, D.
Palmer, A.
Aguado-Maestro, I.
Bardaji, M. F. Bravo
Brañas, F.
Bueno, G. Adrados
Caeiro-Rey, J. R.
Cano, I. Andrés
Barres-Carsi, M.
Delgado, L. Gracia
Salomó-Domènech, M.
Etxebarria-Foronda, I.
Ferrer, B. Llado
Mills, S.
Herrando, L. Ezquerra
Mifsut, D.
Evangelista, L. D. R.
Nogués, X.
Perez-Coto, I.
Blasco, J. Martínez-Iñiguez
Martín-Hernández, C.
Kessel, H.
Serra, J. Teixidor
Solis, J. Rodriguez
Suau, O. Torregrosa
Vaquero-Cervino, E.
Hernández, C. Pablos
Mañas, L. Rodríguez
Herrera, A.
Díez-Perez, A.
Funding for this research was provided by:
University of Oxford
Article History
Received: 18 February 2019
Accepted: 13 May 2019
First Online: 29 May 2019
Compliance with ethical standards
:
: ADP is advisor or speaker for Amgen/UCB, Roche, Gilead, EchoLight and Lilly. Institutional grant EchoLight and Kiowa-Kirin and Shareholder Active Life Sci. DPA’s research group has received unrestricted research grants from Servier, Amgen and UCB; and speaker and consultancy fees from Amgen and UCB. All other authors report no conflict of interests.